Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13661215
[patent_doc_number] => 10160759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 15/952234
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3352
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952234
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952234 | Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor | Apr 12, 2018 | Issued |
Array
(
[id] => 17938366
[patent_doc_number] => 11472807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders
[patent_app_type] => utility
[patent_app_number] => 16/604330
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 37
[patent_no_of_words] => 17380
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604330 | Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders | Apr 8, 2018 | Issued |
Array
(
[id] => 17192080
[patent_doc_number] => 11160809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => NK1-antagonist combination and method for treating synucleinopathies
[patent_app_type] => utility
[patent_app_number] => 16/604468
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18280
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604468 | NK1-antagonist combination and method for treating synucleinopathies | Apr 8, 2018 | Issued |
Array
(
[id] => 15524699
[patent_doc_number] => 20200054655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => COMBINATION THERAPIES USING CASPASE-1 DEPENDENT ANTICANCER AGENTS AND PGE2 ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/603502
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603502 | Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists | Apr 5, 2018 | Issued |
Array
(
[id] => 15008363
[patent_doc_number] => 10450297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Sulfonyl amide derivatives for the treatment of abnormal cell growth
[patent_app_type] => utility
[patent_app_number] => 15/946117
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40348
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946117 | Sulfonyl amide derivatives for the treatment of abnormal cell growth | Apr 4, 2018 | Issued |
Array
(
[id] => 13478911
[patent_doc_number] => 20180290998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES
[patent_app_type] => utility
[patent_app_number] => 15/945334
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945334 | METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES | Apr 3, 2018 | Abandoned |
Array
(
[id] => 15451121
[patent_doc_number] => 20200038384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => DIHYDROTETRABENAZINE FOR THE TREATMENT OF ANXIETY AND PSYCHOSES
[patent_app_type] => utility
[patent_app_number] => 16/498697
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498697 | Dihydrotetrabenazine for the treatment of anxiety and psychoses | Mar 28, 2018 | Issued |
Array
(
[id] => 16421881
[patent_doc_number] => 20200347079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => NOVEL PTEFB INHIBITING MACROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/497578
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497578
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497578 | PTEFb inhibiting macrocyclic compounds | Mar 21, 2018 | Issued |
Array
(
[id] => 13519393
[patent_doc_number] => 20180311239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
[patent_app_type] => utility
[patent_app_number] => 15/923015
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 180704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923015
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923015 | Heteroaryl compounds useful as inhibitors of sumo activating enzyme | Mar 15, 2018 | Issued |
Array
(
[id] => 16892023
[patent_doc_number] => 11033549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Use of heterocyclic compounds in the treatment of pigmented skin
[patent_app_type] => utility
[patent_app_number] => 16/493317
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12253
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493317
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493317 | Use of heterocyclic compounds in the treatment of pigmented skin | Mar 13, 2018 | Issued |
Array
(
[id] => 13413103
[patent_doc_number] => 20180258094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => GLUCURONIDE PRODRUGS OF TOFACITINIB
[patent_app_type] => utility
[patent_app_number] => 15/914189
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/914189 | Glucuronide prodrugs of tofacitinib | Mar 6, 2018 | Issued |
Array
(
[id] => 17096868
[patent_doc_number] => 20210284659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => INHIBITORS OF BETA SECRETASE
[patent_app_type] => utility
[patent_app_number] => 16/489856
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489856 | INHIBITORS OF BETA SECRETASE | Mar 5, 2018 | Abandoned |
Array
(
[id] => 17185175
[patent_doc_number] => 20210332060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => A Simple Process for Preparing Avibactam
[patent_app_type] => utility
[patent_app_number] => 16/345791
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 322
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345791 | Simple process for preparing avibactam | Mar 5, 2018 | Issued |
Array
(
[id] => 15323983
[patent_doc_number] => 20200002321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => OXAZOLIDINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR TREATING BACTERIAL INFECTIONS, INCLUDING INFECTION OF MYCOBACTERIUM TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 16/489234
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489234
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489234 | Oxazolidinones and pharmaceutical compositions thereof for treating bacterial infections, including infection of | Feb 25, 2018 | Issued |
Array
(
[id] => 15556595
[patent_doc_number] => 20200062709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHOD OF PRODUCING PENTAFLUOROSULFANYL AROMATIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/489275
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489275 | Method of producing pentafluorosulfanyl aromatic compound | Feb 25, 2018 | Issued |
Array
(
[id] => 13774613
[patent_doc_number] => 20190000845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/903337
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15903337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/903337 | PHENYLOXADIAZOLE DERIVATIVES AS PGDS INHIBITORS | Feb 22, 2018 | Abandoned |
Array
(
[id] => 13386197
[patent_doc_number] => 20180244640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 15/902802
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902802
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/902802 | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | Feb 21, 2018 | Issued |
Array
(
[id] => 12862090
[patent_doc_number] => 20180179204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
[patent_app_type] => utility
[patent_app_number] => 15/900737
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900737
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900737 | Inhibitors of lysine specific demethylase-1 | Feb 19, 2018 | Issued |
Array
(
[id] => 15324015
[patent_doc_number] => 20200002337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => DIHYDROPYRIDOPHTHALAZINONE COMPOUNDS AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) FOR TREATMENT OF DISEASES AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/487919
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487919 | DIHYDROPYRIDOPHTHALAZINONE COMPOUNDS AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP) FOR TREATMENT OF DISEASES AND METHOD OF USE THEREOF | Feb 8, 2018 | Abandoned |
Array
(
[id] => 16051289
[patent_doc_number] => 20200187499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => SUBSTITUTED BENZYL-4-AMINOPICOLINIC ESTERS AND PYRIMIDINO-4-CARBOXYLIC ESTERS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS
[patent_app_type] => utility
[patent_app_number] => 16/483672
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483672
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483672 | SUBSTITUTED BENZYL-4-AMINOPICOLINIC ESTERS AND PYRIMIDINO-4-CARBOXYLIC ESTERS, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | Feb 5, 2018 | Abandoned |